AU2001293751A1 - Use of triazinetrione sulfoxides for controlling coccidioses - Google Patents

Use of triazinetrione sulfoxides for controlling coccidioses

Info

Publication number
AU2001293751A1
AU2001293751A1 AU2001293751A AU9375101A AU2001293751A1 AU 2001293751 A1 AU2001293751 A1 AU 2001293751A1 AU 2001293751 A AU2001293751 A AU 2001293751A AU 9375101 A AU9375101 A AU 9375101A AU 2001293751 A1 AU2001293751 A1 AU 2001293751A1
Authority
AU
Australia
Prior art keywords
triazinetrione
sulfoxides
coccidioses
controlling
controlling coccidioses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001293751A
Other languages
English (en)
Inventor
Gisela Greif
Iris Heep
Hans-Christian Mundt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2001293751A1 publication Critical patent/AU2001293751A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
AU2001293751A 2000-08-17 2001-08-10 Use of triazinetrione sulfoxides for controlling coccidioses Abandoned AU2001293751A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10040110 2000-08-17
DE10040110A DE10040110A1 (de) 2000-08-17 2000-08-17 Verwendung von Triazintrion-Sulfoxiden zur Bekämpfung von Coccidiosen
PCT/EP2001/009244 WO2002013831A1 (de) 2000-08-17 2001-08-10 Verwendung von triazintrion-sulfoxiden zur bekämpfung von coccidiosen

Publications (1)

Publication Number Publication Date
AU2001293751A1 true AU2001293751A1 (en) 2002-02-25

Family

ID=7652673

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001293751A Abandoned AU2001293751A1 (en) 2000-08-17 2001-08-10 Use of triazinetrione sulfoxides for controlling coccidioses

Country Status (14)

Country Link
US (1) US20030181451A1 (ja)
EP (1) EP1311271A1 (ja)
JP (1) JP2004506016A (ja)
KR (1) KR20030019903A (ja)
CN (1) CN1469747A (ja)
AU (1) AU2001293751A1 (ja)
BR (1) BR0113294A (ja)
CA (1) CA2419414A1 (ja)
DE (1) DE10040110A1 (ja)
HU (1) HUP0301561A3 (ja)
MX (1) MXPA03001432A (ja)
PL (1) PL360630A1 (ja)
WO (1) WO2002013831A1 (ja)
ZA (1) ZA200301226B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102285930B (zh) * 2011-08-12 2013-07-03 中国农业科学院上海兽医研究所 一种三嗪化合物及其在控制鸡球虫病中的应用
CN102973497A (zh) * 2012-12-13 2013-03-20 江苏恒丰强生物技术有限公司 一种托曲珠利溶液及其制备方法
KR20200126988A (ko) 2018-02-26 2020-11-09 알제큐어 파마 에이비 뉴로트로핀과 관련된 질병을 치료하기 위한 트리아진 유도체
EP3578181A1 (en) * 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulation for use in the simultaneous treatment of coccidial infections and iron deficiencies
GB201810668D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2718799A1 (de) * 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
DE3408768A1 (de) * 1984-03-09 1985-09-12 Bayer Ag, 5090 Leverkusen Immunstimulierende mittel
US4837029A (en) * 1987-04-06 1989-06-06 Carolina Medical Products, Inc. Low foaming, aqueously homogenizable rifampin composition
US5859028A (en) * 1997-04-28 1999-01-12 Potomax Limited Partnership Carotenoid synthesis inhibiting herbicides and fatty acid synthesis inhibiting oxime herbicides as anti-Apicomplexa protozoan parasite agents
DE19824483A1 (de) * 1998-06-02 1999-12-09 Bayer Ag Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon
EP1140101A1 (en) * 1998-12-22 2001-10-10 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
US6194408B1 (en) * 1998-12-22 2001-02-27 Bayer Corporation Triazineone compounds for treating diseases due to Sarcocystis, Neospora and Toxoplasma

Also Published As

Publication number Publication date
KR20030019903A (ko) 2003-03-07
HUP0301561A3 (en) 2004-11-29
DE10040110A1 (de) 2002-02-28
CN1469747A (zh) 2004-01-21
JP2004506016A (ja) 2004-02-26
BR0113294A (pt) 2003-07-08
US20030181451A1 (en) 2003-09-25
MXPA03001432A (es) 2004-05-04
ZA200301226B (en) 2004-02-16
WO2002013831A1 (de) 2002-02-21
CA2419414A1 (en) 2002-02-21
PL360630A1 (en) 2004-09-20
EP1311271A1 (de) 2003-05-21
HUP0301561A2 (hu) 2003-09-29

Similar Documents

Publication Publication Date Title
AU2001296981A1 (en) Chair control
AU2001234591A1 (en) Controlling activation of devices
AU3390401A (en) Joystick controller
AU2001270423A1 (en) Surface-modified implants
AU2001268275A1 (en) Switched uniformity control
AU2001228848A1 (en) Sanitary ware
AU2002253836A1 (en) Aptamer-mediated regulation of gene expression
AU2001285258A1 (en) Analog control
AU2001251138A1 (en) Compositions and methods for tissue specific gene regulation therapy
AU2001293751A1 (en) Use of triazinetrione sulfoxides for controlling coccidioses
AU2001281950A1 (en) Regulation of human thimet oligopeptidase-like enzyme
AU2273500A (en) Hand controller
AU2001274080A1 (en) Regulation of human transketolase-like enzyme
AU2001269095A1 (en) Regulation of human caspase-1-like protease
AU2001250514A1 (en) Voltage control
AU2002238803A1 (en) Formulation for treating body odour
AU6389500A (en) Network control architecture for user control of network
AU2001256350A1 (en) Regulation of human lysostaphin-like protease
AU2002215942A1 (en) Regulation of human carboxylesterase-like enzyme
AU2002210525A1 (en) Regulation of human phospholipase-like enzyme
AU2001285782A1 (en) Regulation of human phosphodiesterase-like enzyme
AU2001281969A1 (en) Regulation of human carboxylesterase-like enzyme
AU5621501A (en) Regulation of human ephrin-like receptor
AU5033101A (en) Regulation of human heparanase-like enzyme
AU2002219046A1 (en) Regulation of human ceruloplasmin-like protein

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application